The prognostic importance of e-cadherin and p53 gene expression in transitional bladder carcinoma patients

International Urology and Nephrology

Volumn 37, Issue 3, 2005, Pages 485-492

  Serdar, Arisan ^a   Turhan, Caskurlu ^a   Soner, Guney ^a   Cem, Sonmez Nurettin ^a   Bayram, Keles ^a   Damla, Buyuktuncer Elif ^b,c   Erbil, Ergenekon ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b HALIC UNIVERSITY   (Turkey)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

E cadherins; Immunohistochemistry; p53; Prognosis; TCC; Tumor markers

Indexed keywords

BCG VACCINE; PARAFFIN; PROTEIN P53; UVOMORULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PROGNOSIS; STATISTICAL SIGNIFICANCE; TISSUE SECTION; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; CADHERINS; CARCINOMA, TRANSITIONAL CELL; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 28844448630     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-005-0919-4     Document Type: Article

References (34)

1. RT Greenlee MB Hill-Harmon T Murray M. Thun 2001 Cancer statistics 2001 CA Cancer J Clin 51 15-19 11577478 1:STN:280:DC%2BD3MrjtFGisg%3D%3D
2. SJ Cutler NM Heney GH. Friedell 1982 Longitudinal study of patients with bladder cancer: Factors associated with disease recurrence and progression. In: WW Bonney GR Prout Jr Bladder, eds. cancer, Vol. 1 Williams & Wilkins Baltimore, MD 35-46
3. LG. Koss 1979 Mapping of the urinary bladder: Its impact on the concepts of bladder cancer Hum Pathol 10 (5) 533527959 1:STN:280:Bi%2BC3MvivVw%3D
4. Sana Al-S, Hussain M. Molecular biology of transitional cell carcinoma. Crit Rev Oncol/Hematol Uncorrected proof, 2003.
5. M Hollstein D Sidransky B. Vogelstein 1991 p53 mutations in human cancers Science 253 49-53 1905840 1:CAS:528:DyaK3MXks1Gmurg%3D
6. AJ Levine J Momand CA. Finlay 1991 The p53 tumour suppressor gene Nature 351 453-456 10.1038/351453a0 2046748 1:CAS:528:DyaK3MXksVaku7g%3D
7. C Cordon-Cardo G Dalbagni GT Saez et al. 1994 p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns Int J Cancer 56 347-353 7906253 1:STN:280:ByuC2cfltlw%3D
8. D Esrig CHD Spruck PW Nichols et al. 1993 p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer Am J Pathol 143 1389-1397 7901994 1:STN:280:ByuD2Mnms1U%3D
9. AS Sarkis G Dalbagni C Cordon-Cardo et al. 1993 Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression J Natl Cancer Inst 85 53-59 7677935 1:STN:280:ByyD1MrhsVw%3D
10. CHD Spruck PF Ohneseit M Gonzalez-Zulueta et al. 1994 Two molecular pathways to transitional cell carcinoma of the bladder Cancer Res 54 784-788 8306342 1:CAS:528:DyaK2cXhs1SgsLY%3D
11. M. Takeichi 1991 Cadherin cell adhesion receptors as a morphogenetic regulator Science 251 1451-1455 2006419 1:CAS:528:DyaK3MXhvVSnsbg%3D
12. D Buyuktuncer S Arisan K. Ozdilli 2003 E-cadherin molecular mechanism in prostate cancer J Cell Mol Biol. 2 3-10
13. PK Lipponen M.J. Eskelinen 1995 Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer J Cancer Res Clin Oncol 121 303-308 7768969 1:STN:280:ByqB1cnms1I%3D
14. KN Syrigos T Krausz J Waxman et al. 1995 E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival Int J Cancer 64 367-370 8550236 1:CAS:528:DyaK28XhsFSrsb4%3D
15. S Wakatsuki R Watanabe K Saito et al. 1996 Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder Cancer Lett 103 11-17 10.1016/ 0304-3835(96)04194-8 8616803 1:CAS:528:DyaK28XisFWhsbk%3D
16. T Shimazui JA Schalken LA Giroldi et al. 1996 Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors Cancer Res 56 4154-4158 8797585 1:CAS:528:DyaK28XlslGgtr0%3D
17. T Otto W Birchmeier U Schmidt et al.1994 Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas Cancer Res 54 3120-3123 8205527 1:STN:280:ByuB28rhsFY%3D
18. SF Shariat AZ Weizer A Green et al. 2000 Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder Urology 56 735-740 11068290 1:STN:280:DC%2BD3crhtlWmug%3D%3D
19. A Mialhe J Louis S Montlevier et al. 1997 Expression of E-cadherin and alpha-, beta- and gamma-catenins in human bladder carcinomas: Are they good prognostic factors? Invas Metastas 17 124-137 1:CAS:528:DyaK1cXlsVWqt7w%3D
20. JS Ross AD Del Rosario HL Figge et al. 1995 E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder Hum Pathol 26 940-944 10.1016/0046-8177(95)90081-0 7672793 1:CAS:528:DyaK2MXotlaktL4%3D
21. NK Syrigos A Karayiannakis EI Syrigou et al. 1998 Abnormal expression of p120 correlates with poor survival in patients with bladder cancer Eur J Cancer 34 2037-2040 10.1016/S0959-8049(98)00279-2 10070307 1:CAS:528:DyaK1MXitVWhug%3D%3D
22. T Imao K Koshida Y Endo et al. 1999 Dominant role of E-cadherin in the progression of bladder cancer J Urol 161 692-696 9915485 1:CAS:528:DyaK1MXms1Gruw%3D%3D
23. K Nakanishi T Kawai C Toritaka et al. 1997 E-cadherin expression in upper-urinary-tract carcinoma Int J Cancer 74 446-449 10.1002/ (SICI)1097-0215(19970822)74:4<446::AID-IJC15>3.0.CO;2-7 9291437 1:CAS:528:DyaK2sXlslKisr8%3D
24. S Dorudi JP Sheffield R Poulsom et al. 1993 E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study Am J Pathol 142 981-986 7682766 1:STN:280:ByyB3srps1Q%3D
25. PP Bringuier R Umbas E Schaafsma et al 1993 Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors Cancer Res 53 3241-245 8324734 1:STN:280:ByyA3MzosFU%3D
26. SB Fox J Fawcett DG Jackson et al. 1994 Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms Cancer Res 54 4539-4546 7519124 1:CAS:528:DyaK2cXltlWhsbY%3D
27. D Sidransky et al. 1992 Molecular genetics and biochemical mechanism in bladder cancer Urol Clin North Am 19 629-639 1441021 1:STN:280:ByyD28bnt1Q%3D
28. RE Hollingsworth WH. Lee et al. 1994 Tumor supressor gene: New prospect for cancer research J Natl Cancer Inst 86 1325-1330
29. O Halevy D Michalovitz M. Oren 1990 Different tumor-derived p53 mutants exhibit distinct biological activities Science 250 4977 113-117 2218501 1:CAS:528:DyaK3MXitFKltQ%3D%3D
30. C Cordon-Cardo VE. Reuter 1997 Alterations of tumor suppressor genes in bladder cancer Semin Diagn Pathol 2 132
31. JP Stein GD Grosfeld DA Ginsberg D Esrig et al. 1998 Prognostic markers in bladder cancer: A contemporary review of the literature J Urol 160 645-659 9720515 1:STN:280:DyaK1czosFCluw%3D%3D
32. Z Popov A Hoznek M Colombel et al. 1997 The prognostic value of p53 nuclear overexpression and MIB 1 as a proliferative marker in transitional cell carcinoma of the bladder Cancer 80 1472-1481 10.1002/ (SICI)1097-0142(19971015)80:8<1472::AID-CNCR15>3.0.CO;2-2 9338472 1:STN:280:ByiH2sfhslM%3D
33. M Tsuji K Kojima Y Murakami et al. 1997 Prognostic volue of Ki-67 antigen and p53 protein in urinary bladder cancer: Imm̈nohistochemical analysis of radikal cystectomy specimens Br J Urol 79 367-372 9117215 1:STN:280:ByiB2czjs1Y%3D
34. V Vatne H Maartman-Moe J. Hoestmark 1994 Flow cytometric DNA and p53 analysis in superficially infiltrating bladder carcinoma Anticancer Res 14 2735-2738 7872710 1:STN:280:ByqC2sjlslc%3D